US 10968166
4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
granted A61PA61P21/00A61P25/00
Quick answer
US patent 10968166 (4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases) held by PTC THERAPEUTICS, INC. expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P21/00, A61P25/00, A61P25/16, A61P27/00